Price$3.47-3.59 (-50.85%)
2026-03-052026-06-08
News · 26 weeks35-33%
2025-12-142026-06-07
Mix2290d
- Other11(50%)
- SEC Filings8(36%)
- Earnings3(14%)
Latest news
25 items- PRBIO-key's RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ETHOLMDEL, N.J., June 04, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that Michael DePasquale, Chairman and CEO, will present online at the RedChip Future Tech Investor Conference: Profiting from Technologies, Transforming Work, Life, and Industry, Wednesday, June 10, 2026 at 3:00 pm ET, followed by a live question-and-answer session. The virtual event provides investors direct access to executive management teams at companies driving innovation across artificial intelligence, automation, digital infrastructure, advanced manufacturing, enterprise softwar
- PRUPDATE: BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit UnionBYNUM, Ala. and HOLMDEL, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced a strategic partnership with BlueAlly, a premier provider of IT solutions and managed services. The partnership debuted with a successful deployment of BIO-key's PortalGuard platform for AOD Federal Credit Union, which was seeking to eliminate friction in the user experience and vulnerabilities associated with traditional Multi-Factor Authentication (MFA) solutions. As sophisticated
- PRBIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit UnionBynum, ALBYNUM, Ala. and HOLMDEL, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced a strategic partnership with BlueAlly, a premier provider of IT solutions and managed services. The partnership debuted with a successful deployment of BIO-key's PortalGuard platform for AOD Federal Credit Union, which was seeking to eliminate friction in the user experience and vulnerabilities associated with traditional Multi-Factor Authentication (MFA) solutions. As sophisticated
- SECSEC Form NT 10-Q filed by BIO-key International Inc.NT 10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ETHOLMDEL, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its first quarter (Q1'26) results and first half of 2026 (1H'26) outlook. BIO-key will host an investor call today at 10:00am ET (details below). Financial Highlights: Q1'26 revenues increased 34% to $2.15M vs. Q1'25 and 74% vs. Q4'25Q1'26 net loss improved to $(165K) vs. $(737K) in Q1'25 and $(1.722M) in Q4'25Q1'26 ending cash and cash equivalents position of $2.24MQ1'26 ending shares outstanding of 1.08M Outlook: Q2'25 revenues expected to rise 65% to approx. $2.8M vs. $1.7M in Q
- SECBIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today's Market Close; BIO-key is Seeking to Restore Nasdaq Listing ExpeditiouslyHOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has received written notification from The Nasdaq Stock Market LLC that the trading of its common stock will be suspended on Nasdaq effective with markets' close today, Tuesday, May 12, 2026. BIO-key has received approval from OTC Markets Group for its common stock to be quoted on the OTC Market under the same symbol commencing May 13, 2026. BIO-key's shares are being suspended because its closing bid price, which has been above $1 the past eight consecutive trading days, did no
- PRBiometric Identity and Authentication Provider BIO-key to host Q1'26 Investor Webcast Monday, May 18th at 10am ETHOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its Q1'26 investor call and webcast on Monday, May 18th at 10 a.m. ET. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session. Call/Webcast Details Date / Time:Monday, May 18th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 1165470 About BIO-key International, Inc. (www.BIO-key.com) BIO-key is revolutioni
- SECBIO-key International Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRFollowing Stockholder Approval, BIO-key Announces 1-for-10 Reverse Stock SplitHOLMDEL, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has approved a 1-for-10 reverse stock split that will become effective with the commencement of trading on April 30, 2026. BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement. BIO-key had approximately 10.9 million shares of common stock issued and outstanding as of April 28, 2026. After giving effect to the 1-for-10 reverse stock
- SECBIO-key International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K FilingHOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2025. The Notification Letter has no immediate effect on the listing or trading of th
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the PeriodHOLMDEL, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, previewed today its business outlook for the first half of 2026 (1H'26) ending June 30, 2026, supported by building software license momentum and strength in hardware revenues. Expected 1H'26 Results: 1H'26 revenues expected to grow 50% to approximately $5M vs. $3.3M in 1H'25Positive net income expected in 1H'26 vs. $1.9M net loss in 1H'25Cash position at the close of 1H'26 is expected to remain in line with $2.7M at year-end 2025 Q1'26 & Q2'26 Expected Revenues: Q1'26 revenues expected to grow 3
- SECSEC Form NT 10-K filed by BIO-key International Inc.NT 10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ETHOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its fourth quarter (Q4'25) and year ended December 31, 2025 (2025) results. BIO-key will host an investor call today at 10:00am ET (details below). Highlights: • 2025 Revenue: $6.1M • 2026 Outlook: Solid revenue growth + improved bottom line • Preliminary Q1'26 Revenue: $2.2M, up 37% vs. Q1'25 and 80% vs. Q4'25 • 2025 Cash Position: $2.7M, up $2.3M vs. $0.4M vs. 2024 BIO-key CEO, Mike DePasquale commented, "We had a broad base of achievements in 2025, the revenue and bottom-line benefits
- PRIdentity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ETHOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its 2025 year-end investor call on Tuesday, March 31st at 10 a.m. ET with results issued prior the market opening. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call Details Date / Time:Tuesday, March 31st at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 4802902 About BIO-key Internati
- SECSEC Form DEF 14A filed by BIO-key International Inc.DEF 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Partners with TD SYNNEX Public Sector (DLT) to Deliver Identity-Bound Biometric and IAM Solutions to the U.S. Public SectorHOLMDEL, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions), a leading technology partner to the U.S. public sector, to bring BIO-key's comprehensive suite of security solutions to federal, state, and local government agencies. DLT is a unit of TD SYNNEX (NYSE:SNX), a leading global end-to-end distributor of technology products, services and solutions. As government entities face increasing mand
- SECSEC Form PRE 14A filed by BIO-key International Inc.PRE 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Surpasses $2M of Military/Defense Sales over Last 12 months with Follow-on Order From Foreign Defense Ministry; Geopolitical Tensions Raise Stakes for Securing Intelligence Against Cyber ThreatsHOLMDEL, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a provider of biometric-centric Identity and Access Management (IAM) solutions, today announced that the cyber-defense unit of a foreign defense ministry placed a $280,000 in new order to expand its deployment of BIO-key's biometric user authentication to additional personnel. The order brings total business booked from this customer in the past 12 months to $1.14M with additional orders expected. Across the broader military and defense sector BIO-key has secured over $2M in total orders over the last 12 months, representing a substantial increase over the year-ago period. Rising geopolitical ten
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
BKYI FAQ
5 questionsWhat does BIO-key International Inc. do?
BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its...Where does BKYI stock trade?
BIO-key International Inc. (BKYI) is listed on NASDAQ.What sector and industry is BKYI in?
BIO-key International Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.What companies are similar to BKYI?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare BKYI side-by-side with any of them on Quantisnow.How can I track BKYI on Quantisnow?
Quantisnow aggregates BIO-key International Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BKYI to receive live email and push alerts on every new disclosure.